BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 15135320)

  • 1. Administration of macrophage colony-stimulating factor mobilized both CD11b+CD11c+ cells and NK1.1+ cells into peripheral blood.
    Misawa E; Sakurai T; Yamada M; Tamura Y; Motoyoshi K
    Int Immunopharmacol; 2004 Jun; 4(6):791-803. PubMed ID: 15135320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intracerebral granulocyte-macrophage colony-stimulating factor induces functionally competent dendritic cells in the mouse brain.
    Mausberg AK; Jander S; Reichmann G
    Glia; 2009 Sep; 57(12):1341-50. PubMed ID: 19229994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IL-17 is a potent synergistic factor with GM-CSF in mice in stimulating myelopoiesis, dendritic cell expansion, proliferation, and functional enhancement.
    Liu B; Tan W; Barsoum A; Gu X; Chen K; Huang W; Ramsay A; Kolls JK; Schwarzenberger P
    Exp Hematol; 2010 Oct; 38(10):877-884.e1. PubMed ID: 20600582
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor protection from the murine T-cell leukemia/lymphoma EL4 by the continuous subcutaneous coadministration of recombinant macrophage-colony stimulating factor and interleukin-2.
    Vallera DA; Taylor PA; Aukerman SL; Blazar BR
    Cancer Res; 1993 Sep; 53(18):4273-80. PubMed ID: 8364923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role for IL-18 in the proliferation and activation of NK1.1+ CD3- cells.
    Tomura M; Zhou XY; Maruo S; Ahn HJ; Hamaoka T; Okamura H; Nakanishi K; Tanimoto T; Kurimoto M; Fujiwara H
    J Immunol; 1998 May; 160(10):4738-46. PubMed ID: 9590219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of early gamma interferon (IFN-gamma) expression during murine listeriosis: identification of NK1.1+ CD11c+ cells as the primary IFN-gamma-expressing cells.
    Chang SR; Wang KJ; Lu YF; Yang LJ; Chen WJ; Lin YH; Chang HH; Wang SL
    Infect Immun; 2007 Mar; 75(3):1167-76. PubMed ID: 17158904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immature dendritic cells (CD11c+ CD3- B220- cells) present in mouse peripheral blood.
    Adachi Y; Toki J; Ikebukuro K; Tomita M; Kaneda H; Tanabe A; Jun L; Minamino K; Suzuki Y; Taketani S; Ikehara S
    Immunobiology; 2002 Oct; 206(4):354-67. PubMed ID: 12437067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of macrophage colony-stimulating factor and interleukin-2 administration on NK1.1(+) cells in mice.
    Misawa E; Sakurai T; Yamada M; Hayasawa H; Motoyoshi K
    Int J Immunopharmacol; 2000 Nov; 22(11):967-77. PubMed ID: 11090705
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of interleukin-4 on the phenotype and function of bone marrow-derived murine dendritic cells generated under serum-free conditions.
    Wells JW; Darling D; Farzaneh F; Galea-Lauri J
    Scand J Immunol; 2005 Mar; 61(3):251-9. PubMed ID: 15787742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phenotypic and functional characterization of long-lived NK cell lines of different maturational status obtained from mouse fetal liver.
    Manoussaka M; Georgiou A; Rossiter B; Shrestha S; Toomey JA; Sivakumar PV; Bennett M; Kumar V; Brooks CG
    J Immunol; 1997 Jan; 158(1):112-9. PubMed ID: 8977181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant human macrophage-colony stimulating factor suppresses the mouse mixed lymphocyte reaction.
    Sakurai T; Yamada M; Simamura S; Motoyoshi K
    Cell Immunol; 1996 Jul; 171(1):87-94. PubMed ID: 8660842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Booster effect of interleukin-2 on natural killer 1.1+ cells stimulated by administration of macrophage colony-stimulating factor in mice.
    Misawa E; Sakurai T; Yamada M; Hayasawa H; Motoyoshi K
    J Immunother; 2003; 26(1):21-30. PubMed ID: 12514426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhancement of the synthetic ligand-mediated function of liver NK1.1Ag+ T cells in mice by interleukin-12 pretreatment.
    Habu Y; Uchida T; Inui T; Nakashima H; Fukasawa M; Seki S
    Immunology; 2004 Sep; 113(1):35-43. PubMed ID: 15312134
    [TBL] [Abstract][Full Text] [Related]  

  • 14. G-CSF and/or M-CSF accelerate differentiation of bone marrow cells into endothelial progenitor cells in vitro.
    Zhang Y; Adachi Y; Iwasaki M; Minamino K; Suzuki Y; Nakano K; Koike Y; Mukaide H; Shigematsu A; Kiriyama N; Li C; Ikehara S
    Oncol Rep; 2006 Jun; 15(6):1523-7. PubMed ID: 16685390
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Accelerated differentiation of bone marrow-derived dendritic cells in atopic prone mice.
    Koike E; Takano H; Inoue K; Yanagisawa R
    Int Immunopharmacol; 2008 Dec; 8(13-14):1737-43. PubMed ID: 18775800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of coadministration of M-CSF and IFN-alpha on NK1.1+ cells in mice.
    Sakurai T; Misawa E; Tanaka-Douzono M; Hagesita H; Nomaguchi K; Tetsuya K; Suzu S; Yamada M; Hayasawa H; Motoyoshi K
    J Interferon Cytokine Res; 2002 Jun; 22(6):701-8. PubMed ID: 12162882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of natural killer cell receptors (CD94/NKG2A) on T cells by the stimulation of G-CSF-mobilized peripheral blood mononuclear cells with anti-CD3 monoclonal antibody and cytokines: a study in stem cell donors.
    Tanaka J; Toubai T; Miura Y; Tsutsumi Y; Kato N; Umehara S; Toyoshima N; Ohta S; Asaka M; Imamura M
    Transplant Proc; 2004 Oct; 36(8):2511-2. PubMed ID: 15561299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GM-CSF promotes differentiation of human dendritic cells and T lymphocytes toward a predominantly type 1 proinflammatory response.
    Eksioglu EA; Mahmood SS; Chang M; Reddy V
    Exp Hematol; 2007 Aug; 35(8):1163-71. PubMed ID: 17562355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of a combined, adenovirus-mediated oncolytic and immunostimulatory tumor therapy.
    Bernt KM; Ni S; Tieu AT; Lieber A
    Cancer Res; 2005 May; 65(10):4343-52. PubMed ID: 15899826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combinational FLt3 ligand and granulocyte macrophage colony-stimulating factor treatment promotes enhanced tumor infiltration by dendritic cells and antitumor CD8(+) T-cell cross-priming but is ineffective as a therapy.
    Berhanu A; Huang J; Alber SM; Watkins SC; Storkus WJ
    Cancer Res; 2006 May; 66(9):4895-903. PubMed ID: 16651446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.